Physician profile
Patrick J Kelty
NPI 1407932304
$2,259.33
in general payments reported to CMS, 2019-2025
27 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $75.64 · 2021: $116 · 2022: $417 · 2023: $306 · 2024: $236 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $275.53 | 2019-2022 | |
| Alcon Vision LLC | $249.30 | 2019-2025 | Unity, Clareon, Simbrinza |
| Alimera Sciences, INC. | $233.22 | 2019-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $229.69 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $186.34 | 2019-2025 | Vabysmo |
| Genentech, INC. | $154.33 | 2019 | |
| Abbvie INC. | $127.15 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $125.95 | 2019-2023 | Cequa |
| Apellis Pharmaceuticals, INC. | $84.56 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $72.93 | 2023-2025 | Izervay |
| Thea Pharma INC. | $63.67 | 2023-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $62.65 | 2019-2021 | |
| Lensar, INC. | $51.59 | 2025 | Lensar Laser System |
| Tarsus Pharmaceuticals, INC. | $49.04 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $37.90 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $35.16 | 2023-2025 | Veracity Surgical, Retina Workplace |
| Rayner Intraocular Lenses Limited | $26.47 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Oyster Point Pharma, INC. | $24.88 | 2023 | Tyrvaya |
| Omeros Corporation | $23.32 | 2019 | |
| Eyepoint US, INC. | $23.25 | 2022 | |
| Bausch & Lomb Americas INC. | $22.90 | 2024 | Miebo, Xiidra |
| Aerie Pharmaceuticals, INC. | $22.19 | 2019 | |
| Sight Sciences, INC. | $21.39 | 2025 | Omni Surgical System |
| Dutch Ophthalmic, USA | $20.72 | 2024 | Eva, Combined Machine, Tissueblue |
| Allergan, INC. | $20.57 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kelty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.